Patent details

EP3641775 Title: COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

Basic Information

Publication number:
EP3641775
PCT Application Number:
EP2018066551
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187318456
PCT Publication Number:
WO2018234433
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
French Title of Invention:
COMBINAISON D'UN INHIBITEUR DE MCL-1 ET D'UNE NORME DE TRAITEMENT DE SOINS POUR LES CANCERS HÉMATOLOGIQUES, UTILISATIONS ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES
German Title of Invention:
KOMBINATION EINES MCL-1-INHIBITORS UND STANDARDBEHANDLUNG VON BLUTKREBS, VERWENDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS
SPC Number:

Dates

Filing date:
21/06/2018
Grant date:
06/12/2023
EP Publication Date:
29/04/2020
PCT Publication Date:
27/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/12/2023
EP B1 Publication Date:
06/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/06/2024
Expiration date:
21/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/11/2023
 
 

Name:
Les Laboratoires Servier
Address:
35, rue de Verdun, 92284 Suresnes Cedex, France (FR)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
WEI, Andrew
Address:
Australia (AU)

2

Name:
MARAGNO, Ana-Leticia
Address:
France (FR)

3

Name:
GENESTE, Olivier
Address:
France (FR)

4

Name:
MOUJALLED, Donia
Address:
Australia (AU)

5

Name:
POMILIO, Giovanna
Address:
Australia (AU)

Priority

1

Priority Number:
201762523389 P
Priority Date:
22/06/2017
Priority Country:
United States (US)

2

Priority Number:
17189550
Priority Date:
06/09/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/519; A61K 31/5377; A61K 31/55; A61P 35/00; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202349
Publication date:
06/12/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages